drugset / Trial / NCT01763437

Intralesional Tetracycline Injection in the Treatment of Chalazia

NCT01763437

Phase 0 Withdrawn The Cleveland Clinic
RandomizedParallel-groupSingle-blindTreatment

Summary

The investigators propose a study to investigate the role of tetracycline injection into chalazia versus observation alone. The investigators hypothesize tetracycline injection will result in a significant decrease in lesion size when compared to observation alone.

Timeline

Start
2014-03
Primary completion
2015-03
Completion
2015-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tetracycline Unknown 0.05 ml Other
Subject Tetracycline Unknown 2 % Other

Indications